Polymyalgia Rheumatica: all 138 studies
Page 2 of 2. Open to participants first (29), then studies with results posted, then the rest; newest registration first within each.
- Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.Status unknownNCT03244709Phase 4
- An Extension Study to Evaluate Long-Term Safety of Subcutaneous (SC) Tocilizumab in Participants With Giant Cell Arteritis (GCA)CompletedNCT03202368Phase 3
- A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)WithdrawnNCT03192969Phase 3
- Polymyalgia Rheumatica and Giant Cell ArteritisStatus unknownNCT02985424
- Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORECompletedNCT02908217Phase 3
- Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia RheumaticaWithdrawnNCT02899026Phase 3
- Lymphocyte and Cytokine Disturbances in Polymyalgia RheumaticaCompletedNCT02888496
- Biomarkers in Giant Cells ArteritisTerminatedNCT02844023Not applicable
- Giant Cell Arteritis and PET Scan (GAPS) StudyCompletedNCT02771483
- Delayed Release Prednisone in PMRTerminatedNCT02702778Phase 2
- Giant Cell Arteritis: Improving Use of Ultrasound EvaluationStatus unknownNCT02523625
- Interest of Medical Imaging in the Diagnostic Strategy Vis a Vis a Suspected Horton DiseaseTerminatedNCT02473029
- Study of Circulating Microparticles in Giant Cell ArteritisStatus unknownNCT02333708
- VCRC Patient Contact Registry Patient-Reported Data Validation StudyCompletedNCT02190942
- Educational Needs of Patients With Systemic VasculitisCompletedNCT02190929
- Vasculitis Illness Perception (VIP) StudyCompletedNCT02190916
- Reproductive Health in Men and Women With VasculitisCompletedNCT02176070
- Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)CompletedNCT02065297
- Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study.CompletedNCT01910038Phase 2
- A Study Assessing the Efficacy and Safety of Lodotra® Compared to Prednisone IR in Subjects Suffering From PMRTerminatedNCT01821040Phase 3
- Carotid Artery Neovascularization in Takayasu's and Giant Cell ArteritisCompletedNCT01795456
- Tocilizumab Effect iN pOlymyalgia RheumaticaCompletedNCT01713842Phase 2
- Prospective Follow-up Study of the Aortic Diameter in Patients With Giant Cell ArteritisCompletedNCT01588483
- Infliximab Therapy in Patients With Refractory Polymyalgia RheumaticaStatus unknownNCT01423591Phase 3
- Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell ArteritisStatus unknownNCT01400464Phase 4
- Short Term Efficacy of a Starting Dose of 12.5 mg of Prednisone in Polymyalgia Rheumatica PatientsCompletedNCT01169597Phase 4
- American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic VasculitisStatus unknownNCT01066208
- Efficacy of Micro-Pulse Steroid Therapy as Induction Therapy in Patients With Polymyalgia RheumaticaStatus unknownNCT00982332Not applicable
- Temporal Artery Biopsy vs ULtrasound in Diagnosis of GCA (TABUL)CompletedNCT00974883
- Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia RheumaticaCompletedNCT00847236
- Etanercept Treatment in the Early Course of Polymyalgia RheumaticaCompletedNCT00524381Phase 3
- Hydroxychloroquine in Giant Cell ArteritisCompletedNCT00430807Phase 3
- Determining Disease Activity Biomarkers in Individuals With Giant Cell ArteritisCompletedNCT00315497
- HECTHOR: Humira to Spare Steroids in Giant Cell ArteritisCompletedNCT00305539Phase 3
- Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.CompletedNCT00138983Phase 3
- A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell ArteritisTerminatedNCT00076726Phase 2
- Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune DiseasesStatus unknownNCT00006055Not applicable
- Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell ArteritisCompletedNCT00004686Phase 2